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What Genetic Testing Teaches About Long-
Term Predictive Health Analytics Regulation 
Sharona Hoffman 
 
The ever-growing phenomenon of predictive health analytics is 
generating significant excitement, hope for improved health 
outcomes, and potential for new revenues.  Researchers are 
developing algorithms to predict suicide, heart disease, stroke, 
diabetes, cognitive decline, future opioid abuse, and other ailments.  
The researchers include not only medical experts, but also 
commercial enterprises such as Facebook and LexisNexis, who may 
profit from the work considerably. This Article focuses on long-term 
disease predictions (predictions regarding future illnesses), which 
have received surprisingly little attention in the legal and ethical 
literature. It compares the robust academic and policy debates and 
legal interventions that followed the emergence of genetic testing to 
the relatively anemic reaction to predictions produced by artificial 
intelligence and other predictive methods.  The paper argues that 
like genetic testing, predictive health analytics raise significant 
concerns about psychological harm, privacy breaches, 
discrimination, and the meaning and accuracy of predictions.  
Consequently, as alluring as the new predictive technologies are, 
they require careful consideration and thoughtful safeguards.  
These include changes to the HIPAA Privacy and Security Rules and 
the Americans with Disabilities Act, careful oversight mechanisms, 
and self-regulation by health care providers.  Ignoring the hazards 
of long-term predictive health analytics and failing to provide data 
subjects with appropriate rights and protections would be a grave 
mistake. 
 
 
                                                            
 Edgar A. Hahn Professor of Law and Professor of Bioethics, Co-Director of 
Law-Medicine Center, Case Western Reserve University School of Law; B.A., 
Wellesley College; J.D., Harvard Law School; LL.M. in Health Law, University 
of Houston; S.J.D. in Health Law, Case Western Reserve University. Author of 
Electronic Health Records and Medical Big Data:  Law and Policy (Cambridge 
University Press 2016).  A huge thank you to Computer Science Professor Andy 
Podgurski for everything he taught me about predictive health analytics and for 
his astute comments on prior drafts. I also thank Melissa Vogley for her skillful 
research assistance. 
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I. INTRODUCTION 
 
The ever-growing phenomenon of predictive health 
analytics is generating significant excitement, hope for improved 
health outcomes, and potential for new revenues.1  Researchers are 
developing algorithms to predict suicide, heart disease, stroke, 
diabetes, cognitive decline, future opioid abuse, and other ailments.2  
In 2017 the Society of Actuaries  found that ninety-three percent of 
health care and health insurance executives that it surveyed believed 
that predictive analytics is important to their future success.3 Indeed, 
experts forecast that predictive health analytics will be a 
commonplace medical tool in the near future.4   
Health care providers can use predictive health analytics for 
treatment purposes in the short term.5   For example, predictive 
health analytics can help physicians identify patients who are at risk 
for hospital re-admission because of complications.6  This Article 
focuses, however, on health analytics that predict health problems 
in the more distant future, which I call “long-term predictive health 
analytics.”  For instance, scientists are developing techniques to 
forecast conditions such as heart disease or cognitive decline that 
are years or decades away.7 
In some instances, such forecasts can be medically beneficial 
because clinicians can commence early screening of affected 
individuals and implement preventive interventions.8  In the case of 
                                                            
1 Jennifer Bresnick, 10 High-Value Use Cases for Predictive Analytics in 
Healthcare, HEALTH IT ANALYTICS (Sept. 4, 2018), 
https://healthitanalytics.com/news/10-high-value-use-cases-for-predictive-
analytics-in-healthcare.  
2 See infra Parts II.B & C. 
3 Society of Actuaries, Predictive Analytics in Healthcare Trend Forecast 2, 4 
(2017), https://www.soa.org/Files/programs/predictive-analytics/2017-health-
care-trend.pdf. The survey included 223 participants.  Id. at 2. 
4 Eric J. Topol, High-Performance Medicine: the Convergence of Human and 
Artificial Intelligence, 25 NATURE MED. 44, (2019). 
5 I. Glenn Cohen et al., The Legal and Ethical Concerns that Arise from Using 
Complex Predictive Analytics in Healthcare, 33 HEALTH AFF. 1139, 1140 (2014) 
(explaining that “it has become possible to apply predictive analytics to health 
care”). 
6 Id. 
7 See infra Parts II.B. & C. 
8 Bresnick, supra note 1. 
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heart disease, these might include drugs, exercise, and improved 
diet.9 
At the same time, predictive health analytics can also be 
potentially harmful.10  Individuals who are identified as being at 
high risk of developing future health problems such as cognitive 
decline or opioid addiction may suffer psychological distress, 
privacy violations (if the information is circulated to unauthorized 
third parties), discrimination, and other harms.11  One scholar 
worries that people labelled as being at high risk for suicide will be 
treated differently by their physicians.12  Physicians might 
discontinue beneficial medications for fear that they will exacerbate 
the suicide risk, unnecessarily send police to patients’ homes, 
forcibly hospitalize individuals, or relate to them in a demeaning, 
dehumanizing way.13 
Moreover, predictive health analytics outcomes can be 
erroneous for a variety of reasons.14  Thus, individuals may endure 
serious adverse consequences based on mistaken predictions, when 
in truth there is no evidence that they are at risk of developing the 
health problems at issue.   
This Article argues that we are doing alarmingly little to 
identify and address the ethical and legal implications of long-term 
predictive health analytics.  This is in stark contrast to policy-
makers’ thoughtful approach to the emergence of genetic testing 
several decades ago.15   
The Article highlights the discrepancy between society’s 
relatively cautious approach to genetic testing and its more cavalier 
approach to predictive analytics.  It argues that scientists must 
carefully consider the benefits and risks of predictive health 
analytics and implement safeguards to address their hazards.   
Data subjects should enjoy specified rights that give them a 
degree of control over their data, including predicted health 
outcomes.  They should have an expanded right to consent to 
                                                            
9 Strategies to Prevent Heart Disease, MAYO CLINIC (Jan. 9, 2019), 
https://www.mayoclinic.org/diseases-conditions/heart-disease/in-depth/heart-
disease-prevention/art-20046502. 
10 See infra Part IV. 
11 Id. 
12  Mason Marks, Artificial Intelligence Based Suicide Prediction, YALE J. 
HEALTH POL’Y L. & ETHICS __ (forthcoming) 
13 Id. at __. 
14 See infra Part IV. 
15 See infra Part III. 
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disclosure of their health information, a right to discover who has 
seen their health data, and a right to sue for privacy breaches that 
harm them and for discrimination based on disease predictions.16  
The scientific community should also develop an oversight 
mechanism to safeguard the quality of predictive models.17   
The remainder of the Article proceeds as follows.  Part II 
describes long-term predictive health analytics and illustrates the 
work that scientists are conducting in this area.  Part III analyzes the 
precedent of genetic testing, focusing on the concerns that it raised 
and the measures that policy-makers implemented to address them.  
Part IV examines the risks of long-term predictive health analytics. 
Part V develops preliminary recommendations for responsive legal 
and policy changes.  Part VI concludes. 
 
II. LONG-TERM PREDICTIVE HEALTH ANALYTICS 
 
A. Predictive Health Analytics Defined 
Predictive analytics can be defined as “the analysis of large data 
sets to discover patterns and use those patterns to forecast or predict 
the likelihood of future events.”18  Experts conduct this analysis 
using computer algorithms.19 An algorithm is a precise step-by-step 
process that leaves nothing to guesswork or intuition.20  Learning 
algorithms train predictive models using training sets comprised of 
sample input and output values.21  Some analysts use the term 
“predictive modeling” which can be defined as “the process of 
developing a mathematical tool or model that generates an accurate 
prediction.”22  Researchers often use the terms “learning algorithm” 
and “predictive model” interchangeably, although the term 
“predictive model” suggests a representation of knowledge that is 
                                                            
16 See infra Part V.A.1 & 2. 
17 See infra Part V.B.1. 
18 David Crockett et al., What is Data Mining in Healthcare? HEALTHCATALYST 
(2017) https://www.healthcatalyst.com/wp-content/uploads/2014/06/What-is-
data-mining-in-healthcare.pdf.   
19 I. Glenn Cohen et al., supra note 5, at 1139; Nicholson Price, Regulating Black-
Box Medicine, 116 MICH. L. REV. 421, 425-26 (2017) (discussing the nature of 
medical algorithms). 
20 Deven R. Desaia & Joshua A. Kroll, Trust but Verify:  A Guide to Algorithms 
and the Law, 31 HARV. J.L. & TECH. 1, 23 (2017). 
21 SHAI SHALEV-SHWARTZ & SHAI BEN DAVID, UNDERSTANDING MACHINE 
LEARNING 13-14 (2014) (discussing “the statistical learning framework”). 
22 MAX KUHN & KJELL JOHNSON, APPLIED PREDICTIVE MODELING 2 (2013). 
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created by an algorithm.23  Predictive analysis is based on 
techniques from three closely related areas of research:  statistical 
inference, data mining, and machine learning. 
Statistical inference involves analyzing a dataset and, based 
on this sample, inferring properties of a larger population and 
characterizing uncertainties about them.24  Data mining is the 
process of using algorithms to examine “big data” from sources such 
as databases or the Internet in order to unearth hidden knowledge or 
patterns.25  “Big data” can be defined as data that is of high volume, 
variety, and velocity, the latter of which refers to the speed with 
which it is generated.26  In medicine, big data can come from a 
myriad of sources, including patients, health care providers, 
insurers, manufacturers, the government, and even mobile devices 
such as smartphones and wearables.27 
Machine learning refers to methods that enable computers to 
“automatically detect patterns in data, and then use the uncovered 
patterns to predict future data, or to perform other kinds of decision-
making under uncertainty.”28  Scientists train computers to do 
analytical work by feeding them information, such as patients’ 
medical records.29  For example, scientists might show computers a 
large number of tumor images with indications as to which ones are 
                                                            
23 See supra notes 21-22 and accompanying text. 
24 WILLIAM L. HAYS, STATISTICS 1 (4TH ed. 1988) (describing statistical inference 
as a process of analysis that enables one to “make general statements about the 
large body of potential observations, of which the data collected represents but a 
sample”); Statistical Inference, OXFORD LIVING DICTIONARIES, 
https://en.oxforddictionaries.com/definition/us/statistical_inference (last visited 
Feb. 25, 2019) (defining statistical inference as “[t]he theory, methods, and 
practice of forming judgments about the parameters of a population and the 
reliability of statistical relationships, typically on the basis of random sampling”). 
25 JIAWEI HAN ET AL., DATA MINING:  CONCEPTS AND TECHNIQUES 8 (3RD ED. 
2012). 
26 SHARONA HOFFMAN, ELECTRONIC HEALTH RECORDS AND MEDICAL BIG DATA:  
LAW AND POLICY 111 (2016). 
27 Nathan Cortez, Substantiating Big Data in Health Care, 14 I/S:  J.L. & POL’Y 
FOR INFO. SOC’Y 61, 63-65 (2017) (discussing the breadth of big data sources). 
28 KEVIN P. MURPHY, MACHINE LEARNING:  A PROBABILISTIC PERSPECTIVE 1 
(2012).  See also, David Lehr & Paul Ohm, Playing with the Data: What Legal 
Scholars Should Learn about Machine Learning, 51 U.C. DAVIS L. REV. 653, 671 
(2017) (“Fundamentally, machine learning refers to an automated process of 
discovering correlations (sometimes alternatively referred to as relationships or 
patterns) between variables in a dataset, often to make predictions or estimates of 
some outcome.”). 
29 See Niha Beig et al., Perinodular and Intranodular Radiomic Features on Lung 
CT Images Distinguish Adenocarcinomas from Granulomas, 290 RADIOLOGY 
783, 784 (2019) (relating that a “machine classifier was trained on a cohort of 145 
patients”).  
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cancerous and which ones are not.30  The computers then learn to 
differentiate between benign and malignant tumors based on 
patterns in the tumor x-rays or scans, so that they can identify 
cancerous tumors when shown new images.31 
A well-known type of machine learning is deep learning, 
which allows computers “to learn from experience and understand 
the world in terms of a hierarchy of concepts, with each concept 
defined through its relation to simpler concepts.”32  Thus, computers 
gather knowledge from experience and learn more complex 
concepts by building on simpler concepts.33  Many readers will be 
familiar with the general term “artificial intelligence,” which refers 
to computers’ ability to mimic human behavior and learn.34 
Predictive models are valuable for physicians, researchers, 
and policy makers.35  They can help public health officials identify 
those who are at highest risk of developing a disease so they can 
implement preventive interventions for them.36  In the clinical 
setting, predictive models may discern which patients are likely to 
have poor and successful treatment outcomes so physicians can 
tailor their medical decisions accordingly.  Predictive analytics may 
also help identify high-risk individuals whom doctors should 
aggressively screen for particular diseases.37   
In addition, predictive health analytics can generate 
projections regarding the health problems that will plague 
individuals in the future.38  These long-term forecasts are the subject 
of this Article.  Such predictions can be beneficial to patients if 
physicians can offer medical interventions to prevent or detect the 
condition at issue at a very early stage.  However, such predictions 
can also render the data subject vulnerable to adverse psychological 
consequences, discrimination, and other harms.39   
 
 
                                                            
30 Id. 
31 Id. at 792. 
32 IAN GOODFELLOW ET AL., DEEP LEARNING 2 (2016). 
33 Id. 
34 Id. 
35 EWOUT W. STEYERBERG, CLINICAL PREDICTION MODELS 1-3, 11 (2009). 
36 Id. at 11-12. 
37 Id. 
38 See infra Parts II.B. and C. 
39 See infra Part IV. 
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B. Long-Term Predictive Health Analytics Examples 
 
 aScientists are working hard to identify physical and behavioral 
clues to individuals’ future health status.  Many studies focus on the 
question of whether there are traits, habits, or other indicators that 
signal that a person is vulnerable to particular diseases in the future. 
 
Medical researchers are investigating biomarkers that can help 
them discern disease risks. A “biomarker” is a “biological molecule 
found in blood, other body fluids, or tissues that is a sign of a normal 
or abnormal process, or of a condition or disease.”40 For example, 
researchers reported in 2014 that in their study, people with lower 
levels of ten phospholipids in their blood were at higher risk of 
suffering cognitive impairments at the time of the blood draw or 
within a few years.41 
 
 A 2018 study found that retinopathy was associated with 
higher rates of cognitive decline over the next twenty years.42  
Retinopathy is a disease that involves the small retinal blood vessels 
in the eye.43   
 
Human eyes can also reveal information about cardiovascular 
risks.  As reported in 2018, researchers from Google and its health-
tech subsidiary, Verily, used machine learning to analyze eye scans 
and medical data from nearly 300,000 patients in order to develop 
an algorithm that can predict individuals’ risk of heart disease.44 
 
                                                            
40  NCI Dictionary of Cancer Terms, NAT’L CANCER INST., 
www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=45618 (last 
visited Mar. 7, 2019). 
41  Alison Abbott, Biomarkers Could Predict Alzheimer’s Before It Starts, 
NATURE, Mar. 9, 2014, available at www.nature.com/news/biomarkers-could-
predict-alzheimer-s-before-it-starts-1.14834. 
42  Jennifer A. Deal et al., Retinal Signs and 20-year Cognitive Decline in the 
Atherosclerosis Risk in Communities Study, 90 NEUROLOGY e1158, e1158 (2018).  
The study involved 12,317 men and women who were 50 to 73 years of age when 
they were first examined. 
43 Janet M. Torpy et al., Retinopathy, 298 JAMA. 944, 944 (2007). 
44  Ryan Poplin et al., Prediction of Cardiovascular Risk Factors from Retinal 
Fundus Photographs via Deep Learning,  2 NATURE BIOMEDICAL ENGINEERING 
158, 158 (2018); James Vincent, Google’s New AI Algorithm Predicts Heart 
Disease by Looking at Your Eyes, THE VERGE (Feb. 19, 2018) (“As with all deep 
learning analysis, neural networks were then used to mine this information for 
patterns, learning to associate telltale signs in the eye scans with the metrics 
needed to predict cardiovascular risk (e.g., age and blood pressure).”). 
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 IBM researchers “identified an automated machine-learning 
speech classifier” that could predict psychosis based on the speech 
patterns of high-risk patients.45  The technique relied on indicators 
such as less semantic coherence and diminished use of possessive 
pronouns, and it reportedly achieved an eighty-three percent 
accuracy rate.46 
 Electronic documentation has been particularly helpful for 
purposes of health predictions.  In 2014, IBM announced that it had 
analyzed electronic health records from Virginia’s Carilion Clinic 
and been able to identify 8,500 patients who were at risk of heart 
failure.47  Scientists have also been able to use analysis of electronic 
health records and medical claims data to predict which individuals 
will develop depression or diabetes-related problems up to a year in 
advance.48  The VA has launched a program called “VA Reach Vet” 
by which it uses a predictive model to analyze veterans’ electronic 
health records to identify individuals at high risk of suicide.49  The 
Society of Actuaries used the Health Care Cost Institute database, 
containing a seven-year record of insurance claims from forty-seven 
million individuals, to predict which patients would have the highest 
costs.50  It found that the most telling factor is prior cost history, 
followed by age, gender, and prescription drug coverage.51 
 
                                                            
45 Cheryl M. Corcoran et al., Prediction of Psychosis Across Protocols and Risk 
Cohorts Using Automated Language Analysis, 17 WORLD PSYCHIATRY 67, 67 
(2018).  
46 Id. 
47 IBM Predictive Analytics to Detect Patients at Risk for Heart Failure, IBM 
NEWS RELEASE, Feb. 19, 2014, available at ;http://www-
03.ibm.com/press/us/en/pressrelease/43231.wss; Mohana Ravindranath, IBM 
Used Predictive Analytics to Find Patients at Risk of Heart Failure, WASH. POST, 
Feb. 20, 2014, www.washingtonpost.com/business/on-it/ibm-used-predictive-
analytics-to-find-patients-at-risk-of-heart-failure/2014/02/20/9b0ddb3c-9a47-
11e3-b88d-f36c07223d88_story.html 
48 Arthur Allen, Big Brother Is Watching Your Waist, POLITICO (July 21, 2014), 
www.politico.com/story/2014/07/data-mining-health-care-109153. 
49 VA REACH VET Initiative Helps Save Veterans Lives: 
Program Signals When More Help Is Needed for At-Risk Veterans, U.S. DEP’T 
VETERANS AFFAIRS (Apr. 3, 2017), 
https://www.va.gov/opa/pressrel/includes/viewpdf.cfm?id=2878.  
50 Brian Hartman et al., Predicting High-Cost Members in the HCCI Database 
(July 20, 2018)  (unpublished manuscript), available at 
https://hartman.byu.edu/files/HartmanOwenGibbs_HighCostClaims.pdf. 
51 Id. at 4. 
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C. Non-Traditional Data Sources for Predictive Health 
Analytics  
Social media has become an increasingly common source of 
data used for predictive health analytics.  Researchers recently 
reported that they used an algorithm to analyze Facebook data from 
close to 1200 consenting users and identified linguistic signals that 
could predict depression.52 
Facebook itself has joined the fray of predictive health analytics.  
Its software now monitors users’ posts to identify those with suicidal 
intent, and an algorithm assigns a risk score ranging from zero to 
one.53  The algorithm interprets phrases such as “Are you okay?” 
paired with “Goodbye” and “Please don’t do this” as clues that 
someone is in distress.54  In cases it assesses as severe, Facebook 
contacts the police, as it did at least 3,500 times in 2018.55  
Unfortunately, police officers who are poorly trained or 
inexperienced may mishandle such “wellness checks,” exacerbating 
the situation and in extreme cases, using deadly force against 
individuals with mental illness.56 
Analysts are turning to other nontraditional data sources as well.  
For example, several years ago, Carolinas Healthcare (now Atrium 
Health) purchased consumer information from data brokers57 in an 
                                                            
52 Johannes C. Eichstaedt et al., Facebook Language Predicts Depression in 
Medical Records, 115 PNAS 11203, 11203, 11207 (2018). 
53 Martin Kaste, Facebook Increasingly Reliant on A.I. To Predict Suicide Risk, 
NPR (Nov. 17, 2018),  https://www.npr.org/2018/11/17/668408122/facebook-
increasingly-reliant-on-a-i-to-predict-suicide-risk; Benjamin Goggin, Inside 
Facebook's Suicide Algorithm: Here's How the Company Uses Artificial 
Intelligence to Predict Your Mental State from Your Posts, BUS. INSIDER (Jan. 6, 
2019), https://www.businessinsider.com/facebook-is-using-ai-to-try-to-predict-
if-youre-suicidal-2018-12.  
54 Mason Marks, Suicide Prediction Technology Is Revolutionary. It Badly Needs 
Oversight, WASH. POST, Dec. 20, 2018, 
https://www.washingtonpost.com/outlook/suicide-prediction-technology-is-
revolutionary-it-badly-needs-oversight/2018/12/20/214d2532-fd6b-11e8-ad40-
cdfd0e0dd65a_story.html?utm_term=.951089ae3f76.  
55 Kaste, supra note 53. 
56 Marks, supra note 12, at ___. 
57 Data brokers are “companies that collect information, including personal 
information about consumers, from a wide variety of sources for the purpose of 
reselling such information to their customers for various purposes . . . .”  FEDERAL 
TRADE COMMISSION, PROTECTING CONSUMER PRIVACY IN AN ERA OF RAPID 
CHANGE 68 (2012), available at 
https://www.ftc.gov/sites/default/files/documents/reports/federal‐trade‐
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effort to use algorithms that identify high-risk patients.58  
Information garnered from credit card purchasing records or grocery 
loyalty cards can indicate whether individuals are buying healthy 
food, smoking, refilling their prescriptions, and have gym 
memberships.59  These data in turn can predict the likelihood that 
someone will have a severe asthma attack or a heart attack.60  
The University of Pittsburgh Medical Center has used patient 
demographic and household information to predict health risks.61  It 
concluded that people who do not reside with children in the home 
and earn less than $50,000 annually are more likely to visit 
emergency rooms rather than to make an appointment with a private 
doctor, which is a much cheaper way to obtain appropriate 
treatments for many conditions.62  Likewise, individuals without a 
car may not be receiving adequate medical care.63  Healthcare 
systems assert that they use such information in order to implement 
preventive and corrective interventions for patients.64  However, 
skeptics have questioned their true motivations, suspecting that cost 
savings are at the heart of the matter and worrying that data mining 
practices compromise patient privacy and damage the physician-
patient relationship.65 
D. Predictive Health Analytics as Big Business 
 
Predictive health analytics have generated business 
opportunities for enterprising organizations. Companies are 
reportedly selling “risk scores” to health care providers and insurers 
to identify patients who are at risk of becoming addicted to or 
                                                            
commission‐report‐protecting‐consumer‐privacy‐era‐rapid‐change‐
recommendations/120326privacyreport.pdf.  See also Janine S. Hiller, Healthy 
Predictions?  Questions for Data Analytics in Health Care, 53 AM. BUS. L.J. 251, 
271-72 (2016) (discussing data brokers and health data streams). 
58 Melanie Hicken, Big Data: Look Who's Buying Your Personal Information, 
CNN MONEY, Sept. 10, 2014, https://money.cnn.com/gallery/pf/2014/09/07/big-
data-personal-information/3.html; Shannon Pettypiece & Jordan Robertson, 
Hospitals, Including Carolinas HealthCare, Using Consumer Purchase Data for 
Information on Patient Health, THE CHARLOTTE OBSERVER, June 27, 2014, 
https://www.charlotteobserver.com/living/health-family/article9135980.html.  
59 Pettypiece & Robertson, supra note 58. 
60 Id. 
61 Id. 
62 Id. 
63 Id. 
64 Id. 
65 Id.  See supra Part IV for discussion of concerns raised by predictive analytics. 
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overdosing on opioids.66  Business giants such as LexisNexis collect 
data from insurance claims, electronic health records, housing 
information, and records relating to patients’ social and family 
connections in order to produce risk scores.67 They do all this 
without asking patients for permission and are not required to seek 
consent by law.68 
 
Data brokers sell other types of information to health care 
providers as well.  LexisNexis and Acxiom sell assessments of 
patients based on “criminal records, online purchasing histories, 
retail loyalty programs and voter registration data.”69  This 
information is used to identify individuals who are at risk of 
requiring costly care or readmission to a hospital.70 
 
Moreover, data brokers routinely supply predictive health 
information to parties outside the health care industry as well. They 
garner data from a myriad of sources such as publicly available 
records, surveys, shopper loyalty programs, social media, magazine 
subscription lists, fitness devices, people’s Internet searches, and 
more.71 They then organize and sell the data, often with personally 
identifying information, to interested third parties, including 
marketers.72  These buyers can use the medical information for 
                                                            
66 Mohana Ravindranath, How Your Health Information Is Sold and Turned into 
‘Risk Scores’, POLITICO (Feb. 3, 2019), 
https://www.politico.com/story/2019/02/03/health-risk-scores-opioid-abuse-
1139978.  See also, Timothy R. Hylan et al., Automated Prediction of Risk for 
Problem Opioid Use in a Primary Care Setting, 16 J. PAIN 380, 385 (2015) 
(discussing use of electronic health records to develop “simple risk stratification 
algorithms to initially alert clinicians to … patients at higher risk for problem 
opioid use”).  
67 Ravindranath, supra note 66. 
68 Id.  See supra notes 142-143 and accompanying text for a discussion of the 
limitations of the HIPAA Privacy Rule. 
69 Mohana Ravindranath, Does Your Doctor Need to Know What You Buy on 
Amazon?,  POLITICO (Oct. 30, 2018), 
https://www.politico.com/story/2018/10/30/the-doctor-will-see-through-you-
now-893437.   
70 Id. 
71 Adam Tanner, Strengthening the Protection of Patient Medical Data, THE 
CENTURY FOUNDATION (Jan. 10, 2017), 
https://tcf.org/content/report/strengthening-protection-patient-medical-
data/?agreed=1; Sam Thielman, Your Private Medical Data Is for Sale – and It's 
Driving a Business Worth Billions, THE GUARDIAN (Jan. 17, 2017), 
https://www.theguardian.com/technology/2017/jan/10/medical-data-
multibillion-dollar-business-report-warns.  
72 Tanner, supra note 71. 
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purposes of predictive analytics, to predict individuals’ future 
behaviors and health needs.73 
 
III. THE PRECEDENT OF GENETIC TESTING 
 Predictive health analytics are novel and exciting, but they 
are not the first mechanism used to predict future health problems.  
A much more familiar and well-established technique is genetic 
testing, also known as DNA testing.74  When genetic testing 
emerged as a prevalent diagnostic and predictive tool, it raised 
significant ethical, legal, and policy concerns.  There is much to be 
learned from the conversations and interventions that followed. 
A.  Predictive Genetic Testing 
In the late 1960s scientists developed the ability to test fetuses 
for Down’s syndrome through a sample of amniotic fluid.75  Fetal 
genetic testing became common beginning in the 1970s, and today 
it is used to screen for Tay-Sachs disease, sickle cell disease, cystic 
fibrosis, and many other illnesses.76   
Genetic testing can also analyze disease risks after birth and 
provide information regarding the likelihood that individuals will 
develop specific maladies in the future.77  In 1990, Mary King-
                                                            
73 Russ Cobb, 2018: Taking Your Healthcare System Marketing Strategies into 
the Consumer Age, BECKER’S HOSPITAL REV. (Dec. 19, 2017), 
https://www.beckershospitalreview.com/patient-engagement/2018-taking-your-
healthcare-system-marketing-strategies-into-the-consumer-age.html. Thielman, 
supra note 71. 
74 Wylie Burke, Genetic Testing, 347 NEW ENG. J. MED. 1867, 1867 (2002) ; 
Frequently Asked Questions about Genetic Testing, NAT’L HUMAN GENOME 
RESEARCH INST., https://www.genome.gov/19516567/faq-about-genetic-testing/ 
(last updated Feb. 13, 2019) (“Genetic testing uses laboratory methods to look at 
your genes, which are the DNA instructions you inherit from your mother and 
your father. Genetic tests may be used to identify increased risks of health 
problems, to choose treatments, or to assess responses to treatments.”); Genetic 
Testing:  How It Is Used for Healthcare, DEP’T OF HEALTH & HUMAN SERVS., 
https://report.nih.gov/nihfactsheets/ViewFactSheet.aspx?csid=43 (last updated 
June 30, 2018). 
75 Glenn E. Palomaki, Screening for Down’s Syndrome, 333 NEW ENGL. J. MED. 
532 (1995).  
76 Nancy Press, Genetic Testing and Screening, in FROM BIRTH TO DEATH AND 
BENCH TO CLINIC: THE HASTINGS CENTER BIOETHICS BRIEFING BOOK FOR 
JOURNALISTS, POLICYMAKERS, AND CAMPAIGNS 73 (Mary Crowley ed., The 
Hastings Center, 2008). 
77 LORI B. ANDREWS ET AL., GENETICS:  ETHICS, LAW, AND POLICY 301 (2015); 
What Are the Types of Genetic Tests?, U.S. NAT’L LIBRARY OF MED., 
https://ghr.nlm.nih.gov/primer/testing/uses (published Feb. 26, 2019). 
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Claire identified a genetic mutation,78 BRCA1, that is linked to 
breast and ovarian cancer, as is BRCA2, which was discovered 
shortly thereafter.79  Since then, scientists have discovered a myriad 
of genetic abnormalities that can increase disease vulnerabilities and 
have developed predictive genetic tests for some of them.80  For 
example, predictive testing can be done for early-onset familial 
Alzheimer’s disease, a variety of cancers, hereditary 
hemochromatosis (a disorder causing iron overload), Huntington’s 
Disease, and more.81 
B. Genetic Testing Concerns 
The advent of genetic testing raised numerous concerns that 
were vigorously debated and catapulted professional and 
governmental bodies into action.  Academics wrote hundreds of 
articles about genetic testing, and law reviews dedicated entire 
symposium issues to the subject.82  In 1995 the National Institutes 
                                                            
78 A mutation “is a permanent alteration in the DNA sequence that makes up a 
gene, such that the sequence differs from what is found in most people.”  What Is 
a Gene Mutation and How Do Mutations Occur?, U.S. NAT’L LIBRARY OF MED., 
https://ghr.nlm.nih.gov/primer/mutationsanddisorders/genemutation (published 
Feb. 26, 2019). 
79 Nancy Press, supra note 76, at 73; Lydia Ramsey, Over a 40-Year Career, This 
'Stubborn Scientist' Helped Change the Way We Think about Cancer and 
Genetics, BUS. INSIDER (Nov. 16, 2017), https://www.businessinsider.com/mary-
claire-king-and-the-impact-brca-genes-had-on-cancer-genetics-2017-11; BRCA1 
& BRCA2 Genes: Risk for Breast & Ovarian Cancer, MEM’L SLOAN KETTERING 
CANCER CTR., https://www.mskcc.org/cancer-care/risk-assessment-
screening/hereditary-genetics/genetic-counseling/brca1-brca2-genes-risk-breast-
ovarian (last visited Feb. 27, 2019).  
80 ANDREWS ET AL., supra note 77, at 301; Burke, supra note 74, at 1870. 
81 Burke supra note 74, at 1870; Learning About Huntington's Disease, NAT’L 
HUMAN GENOME RESEARCH INST., https://www.genome.gov/10001215/learning-
about-huntingtons-disease/ (last updated: Nov. 17, 2011); What Are the Types of 
Genetic Tests?, supra note 77. 
82 See, e.g., The Fifth Annual Health Law Symposium, Communities of Color and 
Genetic Testing: Purpose, Voice, & Values, 27 SETON HALL L. REV. 887 (1997); 
Symposium, The Genetics Revolution: Conflicts, Challenges and Conundra, 28 
AM. J.L. & MED. 145 (2002); Symposium, The Human Genome Initiative and the 
Impact of Genetic Testing and Screening Technologies, 17 AM. J.L. & MED. 1 
(1991); Symposium, Is There a Pink Slip in Your Genes? Genetic Discrimination 
in Employment and in Health Insurance, 16 J.L. & HEALTH 1 (2001-02); 
Symposium, Legal and Ethical Issues Raised by the Human Genome Project, 29 
HOUS. L. REV. 1 (1992); Symposium, Legal Liabilities at the Frontier of Genetic 
Testing (pts. 1 & 2), 41 JURIMETRICS 1 (2000), 41 JURIMETRICS 145 (2001); 
Symposium, Living in the Genetic Age: New Issues, New Challenges, 3 ST. LOUIS 
U. J. HEALTH L. & POL’Y 1 (2009); The Randolph W. Thrower Symposium, Law 
& Human Genetics on the Threshold of the New Millennium, 49 Emory L.J. 745 
(2000); Symposium, Re-defining Disability: Legal Protections for Individuals 
with HIV, Genetic Predispositions to Disease, or Asymptomatic Diseases, 3 J. 
HEALTH CARE L. & POL’Y 225 (2000); Symposium, Testing and Telling?: 
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of Health-Department of Energy Joint Working Group on the 
Ethical, Legal and Social Implications of Human Genome Research 
established a Task Force on Genetic Testing.83  The American 
Academy of Ophthalmology convened such a task force as well.84  
For purposes of illustration, this section will focus on three areas of 
concern out of the many that were considered:  clinical validity and 
predictive accuracy; privacy and discrimination; and psychological 
harms. 
1. Clinical Validity and Predictive Accuracy 
Experts worry about the clinical validity and predictive 
accuracy of genetic test results.85  Many genetic tests identify only 
a fraction of genetic mutations that can cause a disease because 
researchers have yet to discover other mutations or because the price 
of more comprehensive testing is too high.86  Moreover, although a 
subgroup of patients may have an inherited form of a disease such 
as cancer, many others will develop the disease because of 
environmental or other triggers without having genetic mutations.87   
Individuals who undergo genetic testing and receive negative results 
may mistakenly conclude that they are immune to the disease at 
issue.  Thus, a woman who is found not to have the BRCA1 or 
BRCA2 mutation may foolishly decline appropriate screening 
measures, such as routine mammograms and gynecological exams.  
In truth, only five to ten percent of breast and ovarian cancers are 
hereditary, so the vast majority of these diseases have no genetic 
link.88 
A further risk is that the opposite will occur.  An individual 
who receives a positive genetic test result may panic and take 
unnecessarily aggressive preventive measures.89  Many genetic 
mutations are not completely penetrant, that is, not all individuals 
with the abnormality will develop the disease at issue.90  For 
                                                            
Implications for Genetic Privacy, Family Disclosure and the Law, 1 J. HEALTH 
CARE L. & POL’Y 301 (1998). 
83 Task Force on Genetic Testing, NAT’L HUMAN GENOME RESEARCH INST. (Apr. 
1995), https://www.genome.gov/10001808/genetic-testing-task-force/. 
84 See Edwin M. Stone et al., Recommendations for Genetic Testing of Inherited 
Eye Diseases, 119 Ophthalmology 2408 (2012). 
85 Burke supra note 74, at 1871. 
86 Id. 
87 BRCA1 & BRCA2 Genes: Risk for Breast & Ovarian Cancer, supra note 79. 
88 Id. 
89 ANDREWS ET AL., supra note 77, at 301. 
90 What Are Reduced Penetrance and Variable Expressivity?, U.S. NAT’L 
LIBRARY OF MED., 
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example, a woman who tests positive for the BRCA1 mutation has 
only a fifty-five to sixty five percent chance of developing breast 
cancer by the age of seventy.91  Women who fully understand the 
meaning of their test results and the extent of their risk may or may 
not want to undergo prophylactic radical mastectomies, and either 
decision would be rational.     
 Physicians and patients who use genetic testing must be fully 
educated about how to interpret test results and the limitations of the 
information they reveal.  It is all too easy to misconstrue test 
outcomes and attribute more certainty to genetic predictions than 
they warrant.  Such misunderstandings can lead to consequential 
medical treatment missteps. 
2. Privacy and Discrimination 
A dearth of regulation that protected patients against medical 
privacy violations and genetic discrimination led to significant 
concern in legal and policy circles for several decades.92  Until 2003, 
there was no federal law that safeguarded the privacy of health 
information in general, let alone genetic information in particular.93  
Thus, federal law did not prohibit anyone who possessed genetic 
information from disclosing it to third parties. At the state level, a 
patchwork of statutes offered varying degrees of genetic privacy 
protections in some states.94  Moreover, until the passage of the 
Genetic Information Nondiscrimination Act in 2008,95 no federal 
law prohibited third parties such as employers and health insurers 
                                                            
https://ghr.nlm.nih.gov/primer/inheritance/penetranceexpressivity (published 
Feb. 26, 2019) (“Penetrance refers to the proportion of people with a particular 
genetic change (such as a mutation in a specific gene) who exhibit signs and 
symptoms of a genetic disorder.”). 
91 BRCA1 and BRCA2, SUSAN G. KOMEN, 
https://ww5.komen.org/BreastCancer/BRCA1andBRCA2.html (updated Dec. 7, 
2018). 
92 See generally, Eric Mills Holmes, Solving the Insurance/Genetic Fair/Unfair 
Discrimination Dilemma in Light of the Human Genome Project, 85 KY. L.J. 503 
(1997); Pauline T. Kim, Genetic Discrimination, Genetic Privacy: Rethinking 
Employee Protections for a Brave New Workplace, 96 NW. U. L. REV. 1497 
(2002). 
93 HOFFMAN, supra note 26, at 62 (discussing the HIPAA Privacy Rule, which 
became effective in 2003); Karen H. Rothenberg, Breast Cancer, The Genetic 
“Quick Fix,” and The Jewish Community:  Ethical, Legal, and Social Challenges, 
7 HEALTH MATRIX 97, 115 (1997). 
94 Lori B. Andrews, A Conceptual Framework for Genetic Policy: Comparing the 
Medical, Public Health, and Fundamental Rights Models, 79 WASH. U. L.Q. 221, 
280 (2001); Rothenberg, supra note 93, at 115-18;  
95 Genetic Information Nondiscrimination Act of 2008, Pub. L. No. 110-233, 122 
Stat. 881 (codified as amended in scattered sections of 29 & 42 U.S.C.).  
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from demanding that individuals provide genetic information or 
from discriminating on its basis.96 Some states took the lead and 
passed genetic discrimination legislation as early as the 1990s, but 
the protections they offered were inconsistent and often limited.97 
Without comprehensive privacy protection, sensitive genetic 
information could end up in the hands of third parties that could use 
it to promote their own agendas.  The prospect of genetic 
discrimination generated a plethora of literature and many heated 
academic and policy debates.98 
For example, workers worried that employers would obtain 
genetic data through pre-employment or post-employment medical 
examinations.99  Once they learned of individuals’ genetic 
abnormalities, employers could decide to reject them, fire them, 
demote them, or take other adverse actions with impunity.100 
Americans also were apprehensive about the impact of genetic 
testing on health insurance coverage.101  An insurer selling an 
individual policy who obtained data about an applicant’s disease 
risks could potentially decline to insure the person, raise premium 
prices, or dictate other adverse coverage conditions.102  The same 
could be true for other types of insurance, such as long-term care 
plans.103 
3. Psychological Harms 
A third area of concern revolved around psychological harms.  
Individuals who discover that they are at risk of a life-threatening 
disease may suffer depression and even become suicidal.104  They 
                                                            
96 Rothenberg, supra note 93, at 107-114. 
97 Id. at 108-09, 114-15. 
98 See supra notes 82-84 and accompanying text. 
99 Ellen R. Peirce, The Regulation of Genetic Testing in the Workplace – A 
Legislative Proposal, 46 OHIO ST. L.J. 771, 801-04 (1985). 
100 Id. 
101 Andrews, supra note 94, at 258-61. 
102 Id. at 280 (explaining that the law “does not prohibit genetic discrimination 
against people seeking insurance under individual plans” and “does not prohibit 
group insurers from charging higher rates to a whole group 
based on genetic information about a particular individual”); Robert Lowe, 
Genetic Testing and Insurance:  Apocalypse Now? 40 DRAKE L. REV. 507, 510-
11 (1991). 
103 Mark A. Rothstein, Predictive Genetic Testing for Alzheimer's Disease in 
Long-Term Care Insurance, 35 GA. L. Rev. 707 (2001). 
104 Katherine A. Schneider, Adverse Impact of Predisposition Testing on Major 
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may lose motivation to be productive in their careers, experience 
diminished self-esteem, and have difficulty caring for their 
families.105  They may also decide not to get married or have 
children because they expect to die young and do not wish to 
transmit a genetic abnormality to a child.106  On the other hand, some 
patients expect to develop inherited diseases such as breast cancer 
or Huntington’s disease because many of their family members 
suffered from the condition, and they build their lives around this 
assumption.107  Obtaining a negative genetic test result may be just 
as devastating to them.108  They may be confused and depressed by 
the need to reorient their lives and feel “survivors’ guilt” in the face 
of their loved ones’ suffering.109 
The risk of psychological injury is particularly acute in the case 
of testing minors, especially for adult-onset illnesses, such as 
Huntington’s disease.110  Experts questioned whether it was ethical 
to test individuals under the age of eighteen.111  They also pondered 
who should gain access to test results and the extent to which 
clinicians should ask both parents and their children to consent to 
the testing.112    
If preventive measures such as regular screening and curative 
medical interventions are available, genetic testing of children can 
be justified and beneficial.113  However, in the absence of such 
measures, many condemn testing as potentially devastating to 
minors and their family members.  Knowing that they live in the 
shadow of an impending illness could ravage minors’ psychological 
                                                            
Implications of Defining Genetic Risk for Cancers, ANNALS N.Y. ACAD. SCI. 41, 
45-6 (1995) (discussing “psychological issues in women at genetic risk”). 
105 Schneider, supra note 104, at 369 & 372-74. 
106 Id. at 376. 
107 Id. at 374. 
108 Id. 
109 Id. 
110 Kimberly A. Quaid, Genetic Testing for Huntington Disease, in 144 
HANDBOOK OF CLINICAL NEUROLOGY 113, 115-17 (A.S. Feigin & K.E. Anderson 
eds. 2017). For information about Huntington’s disease, see Huntington’s disease, 
MAYO CLINIC, https://www.mayoclinic.org/diseases-conditions/huntingtons-
disease/symptoms-causes/syc-20356117 (last visited Mar. 3, 2019). 
111 ANDREWS ET AL., supra note 77, at 331. 
112 Id. 
113 Am. Soc’y of Human Genetics Bd. of Dirs. & Am. Coll. of Med. Genetics Bd. 
of Dirs., Points to Consider: Ethical, Legal, and Psychosocial Implications of 
Genetic Testing in Children and Adolescents, 57 AM. J. HUMAN GENETICS 1233, 
1233 (1995). 
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wellbeing.114  Likewise, discovery of a child’s genetic abnormality 
may upend family dynamics as the affected child is treated either as 
more precious than others or less favorably because the child does 
not have a promising future.115 
C. Legal and Policy Interventions 
As genetic testing became increasingly common, legislators and 
other policy-makers implemented a variety of measures to address 
the concerns that it raised.  This section will focus on three of these:  
federal and state anti-discrimination legislation, the HIPAA Privacy 
Rule, and self-regulation mechanisms. 
1. State and Federal Anti-Discrimination Legislation 
States began enacting legislation that prohibits genetic 
discrimination as early as the 1970s.116  Early laws focused on 
protecting individuals with the sickle cell trait.117  In 1991, 
Wisconsin was the first state to enact a more comprehensive 
statute.118 Thereafter, the vast majority of states enacted genetic 
anti-discrimination statutes, though they varied significantly in 
scope and contents.119  As applied to health insurers, these laws 
formulated restrictions related to using genetic information to 
determine coverage eligibility or premium levels, requiring 
applicants to undergo genetic testing, or disclosing genetic 
information to others without consent.120  As applied to employers, 
the laws prohibited employers from discriminating on the basis of 
genetic information and from requesting, requiring, or obtaining 
genetic information.121 
                                                            
114 Id. at 1235-36.  At the same time, minors whose test results are negative “may 
develop ‘survivor guilt,’ based on 
the knowledge that one or more of their siblings will develop-and perhaps die 
from-a serious genetic disease.”  Id. at 1236. 
115 Id. at 1236. 
116 ANDREWS ET AL., supra note 77, at 776. 
117 Id. 
118 Id.  See Wisconsin Fair Employment Law, WIS. STAT. § 111.372 (2018). 
119 Genetics and Health Insurance State Anti-Discrimination Laws, NAT’L 
CONFERENCE OF STATE LEGISLATURES, 
http://www.ncsl.org/research/health/genetic-nondiscrimination-in-health-
insurance-laws.aspx (last updated Jan. 2008) [hereinafter State Health Insurance 
Discrimination Laws]; Genetic Employment Laws, NAT’L CONFERENCE OF STATE 
LEGISLATURES, http://www.ncsl.org/research/health/genetic-employment-
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The United States Congress considered genetic 
discrimination bills for thirteen long years.122  Finally, President 
George W. Bush signed the Genetic Information Nondiscrimination 
Act (GINA) into law on May 21, 2008.123  GINA applies to the use 
of predictive genetic information by health insurers and employers.  
The law does not cover those who already manifest symptoms of a 
genetic disease.124 
Title I of the Act prohibits genetic discrimination in health 
insurance.  Health insurers offering group plans may not modify 
premium prices and contribution amounts based on genetic 
information.125  Insurers offering individual health plans may not 
require genetic testing or use genetic information to establish rules 
for eligibility, premium prices, or contribution amounts, or to apply 
preexisting condition exclusions for coverage.126 
GINA’s Title II focuses on employment discrimination. It 
establishes that employers may not discriminate against employees 
in hiring, firing, or other employment practices based on genetic 
information.127  The law defines “genetic information” as including 
genetic testing of both individuals and their family members and 
family disease histories.128  Furthermore, Title II prohibits 
employers from attempting to obtain genetic information about 
applicants or employees by requesting, requiring, or purchasing 
it.129    
 GINA has many critics who decry its arguably anemic 
protections.130  For example, it applies only to health insurers and 
                                                            
122  ANDREWS ET AL., supra note 77, at 777. 
123 Genetic Information Nondiscrimination Act of 2008, supra note 95; President 
Bush Signs the Genetic Information Nondiscrimination Act of 2008, NAT’L 
HUMAN GENOME RESEARCH INST. (May 21, 2008), 
https://www.genome.gov/27026050/president-bush-signs-the-genetic-
information-nondiscrimination-act-of-2008/. 
124 Mark A. Rothstein, GINA’s Beauty Is Only Skin Deep, GENE WATCH, Apr.-
May 2009, at 9, 10 (“The problem is that GINA only applies to asymptomatic 
individuals.”). 
125 29 U.S.C. § 1182(b)(3) (2010). 
126 42 U.S.C. § 300gg-53 (2010).  
127 42 U.S.C. § 2000ff-1(a) (2010). 
128 42 USC § 2000ff(4)(A) (2010) (defining genetic information as “(i) an 
individual’s genetic tests, (ii) the genetic tests of an individual’s family members, 
and (iii) the manifestation of a disease or disorder in an individual’s family 
members”) 
129 42 U.S.C. § 2000ff-1(b) (2010). 
130 See, e.g., Bradley A. Areheart & Jessica L. Roberts, GINA, Big Data, and the 
Future of Employee Privacy, 128 YALE L.J. 710, 745 (2019) (noting that “the 
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employers rather than to all parties that might possess genetic 
information (such as life or disability insurers) and might subject 
individuals to discrimination on its basis.131  GINA also does not 
cover a range of non-genetic biologic information that may be of 
interest to third parties, such as epigenetic markers and the 
microbiome.132 
 A full analysis of GINA or parallel state legislation is beyond 
the scope of this article.  My point here is merely that legislators 
recognized that genetic testing could yield both benefits and serious 
risks.  They were sufficiently thoughtful and concerned about those 
risks to enact statutory interventions, however imperfect.  
2.  The HIPAA Privacy Rule 
The HIPAA Privacy Rule, which went into effect in 2003, is 
a set of federal regulations that address the privacy of health 
information.133  The Privacy Rule establishes that, with some 
exceptions, covered entities134 must obtain patients’ permission to 
disclose their protected health information to third parties.135  As of 
2013, “health information” explicitly includes genetic 
information.136 
Under the HIPAA Privacy Rule, covered entities must allow 
patients to view and obtain copies of their health records and receive 
                                                            
& Rahul Rajkumar, The Genetic Information Nondiscrimination Act — A Half-
Step Toward Risk Sharing, 359 NEW ENG. J. MED. 335, 337 (2008) (criticizing 
“[t]he arbitrary nature of the categories GINA creates”); Rothstein, supra note 
124, at 9 (“Unfortunately, the protections afforded individuals under either state 
laws prohibiting genetic discrimination in health insurance or GINA are not 
particularly robust or valuable.”). 
131 See supra notes 125-129 and accompanying text. 
132 Areheart & Roberts, supra note 130, at 748-49. 
133 45 C.F.R. §§ 160.101–534 (2018); HIPAA for Professionals, U.S. DEP’T OF 
HEALTH & HUMAN SERVS., https://www.hhs.gov/hipaa/for-
professionals/index.html (last reviewed June 16, 2017).  The HIPAA Privacy Rule 
was promulgated pursuant to the Health Insurance Portability and Accountability 
Act of 1996 and was amended in accordance with the Health Information 
Technology for Economic and Clinical Health (HITECH) Act of 2009.  See 42 
U.S.C. §§ 1320d to 1320d-9 (2010); Health Information Technology for 
Economic and Clinical Health (HITECH) Act, Title XIII of Division A and Title 
IV of Division B of the American Recovery and Reinvestment Act of 2009 
(ARRA), Pub. L. No. 111-5 (Feb. 17, 2009). 
134 See infra notes 142-143 for definition of covered entities. 
135 45 C.F.R. §§ 164.508–.510 (2018). 
136 45 CFR § 160.103 (2018); Genetic Information Privacy, ELEC. FRONTIER 
FOUND., https://www.eff.org/issues/genetic-information-privacy (last visited 
Mar. 6, 2019). 
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an accounting of disclosures of their protected health information.137  
In addition, patients can ask health care providers to correct errors 
in their medical records or to use their health data restrictively.138  In 
addition, covered entities that suffer privacy breaches of unsecured 
data, such as hacking occurrences, must notify affected individuals 
and the Department of Health and Human Services, and in instances 
of large breaches, must also notify the media.139 
The related HIPAA Security Rule, which became effective 
in 2005, promotes secure storage and processing of electronic health 
information (EHI).140  It delineates administrative, physical, and 
technical safeguards to protect EHI’s confidentiality, integrity, and 
availability.141 
The HIPAA Privacy and Security Rules offer valuable 
protections to American patients.  However, like the genetic anti-
discrimination statutes, they are limited in scope and have been 
attacked by critics.  For example, “covered entities” include only 
health plans, health care clearinghouses, health care providers who 
transmit health information electronically for purposes of HIPAA-
relevant transactions, and their business associates.142  Therefore, 
other parties that possess and handle health information, such as data 
brokers and marketers, need not comply with the Rules’ privacy and 
security mandates.143 
Another noteworthy regulatory gap in the HIPAA Privacy 
and Security Rules is the absence of a private cause of action.144  
Thus, individuals whose health data is breached cannot sue 
wrongdoers for damages under federal law no matter what 
consequences they suffer.  Instead, the regulations leave 
enforcement solely in the hands of the Department of Health and 
Human Services Office for Civil Rights (OCR) and state attorneys 
                                                            
137 45 C.F.R. §§ 164.520(b)(1)(iv), 164.528 (2018). 
138 45 C.F.R. §§ 164.520(b)(1)(iv), 164.522 (2018). 
139 45 C.F.R. §§ 164.400–.408 (2018).  Entities must notify the media if a breach 
involves “more than 500 residents of a State or jurisdiction.”  Id. § 164.408.  
Unsecured protected health information means information “that is not rendered 
unusable, unreadable, or indecipherable to unauthorized persons through the use 
of a [specified] technology or methodology,” such as encryption. 
140 Sharona Hoffman & Andy Podgurski, In Sickness, Health, and Cyberspace:  
Protecting the Security of Electronic Private Health Information, 48 B.C. L. REV. 
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141 45 C.F.R. §§ 164.302–.318 (2018). 
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general offices, which may or may not have adequate staffing and 
resources for robust prosecutorial activities.145 
In addition, the HIPAA Privacy Rule features numerous 
exceptions.  Covered entities can disclose patients’ medical data for 
purposes of treatment, payment, and health care operations without 
patient authorization.146  Thus, the regulations permit physicians to 
consult colleagues about patients and to ask administrators to review 
records for billing or other office-related purposes without the 
patients’ knowledge. The Rule exempts additional disclosures as 
well, such as those made for law enforcement, public health, and 
other listed purposes.147 In general, these exceptions are reasonable 
and sound.  However, patients should understand that they are often 
ignorant of who is viewing their health data and for what purpose.  
The HIPAA Privacy and Security Rules fall short of 
providing American patients with comprehensive protection.  
Nevertheless, they constitute important advances in the privacy 
arena and address some of the concerns raised by genetic testing.  
3.   Self-Regulation 
Genetic testing professionals also engage in self-regulation, 
formulating practice guidelines and deferring testing until they have 
educated patients about its potential consequences.  For example, 
The American Society of Breast Surgeons issued a “Consensus 
Guideline on Genetic Testing for Hereditary Breast Cancer.”148  The 
guidance formulated recommendations for genetic testing and 
discussed testing limitations.149  The American Society of Human 
Genetics Board of Directors and the American College of Medical 
Genetics Board of Directors published a document entitled “Points 
to Consider: Ethical, Legal, and Psychosocial Implications of 
Genetic Testing in Children and Adolescents.”150  The guidance 
recommended against testing children for adult-onset diseases if 
they will derive no medical or psychological benefit from being 
                                                            
145 45 C.F.R. § 160.306 (2018); 42 U.S.C. § 1320d-5(d) (2010).   
146 45 C.F.R. § 164.506 (2018). 
147 45 C.F.R..§§ 164.502, .512 (2018). 
148 Consensus Guideline on Genetic Testing for Hereditary Breast Cancer, AM. 
SOC’Y OF BREAST SURGEONS, 
https://www.breastsurgeons.org/about/statements/PDF_Statements/Hereditary_
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2019). 
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tested as minors.151  The American College of Medical Genetics and 
Genomics has issued practice guidelines related to genetic testing 
for numerous conditions.152 
Clinicians typically offer genetic counseling to patients who 
are considering genetic testing.153 Counseling is designed to ensure 
that patients make fully informed decisions about pursuing testing, 
in light of the benefits and risks that exist in their particular 
circumstances.154  A variety of health care providers can educate 
patients about genetic testing, but a growing number of practices 
include professional genetic counselors with master’s degrees.155  
The American Board of Genetic Counselors has certified over 4,000 
genetic counselors thus far.156  Thus, rather than rushing to test 
patients after only a brief discussion, responsible clinicians exercise 
a degree of self-restraint and take steps to ensure that patients 
provide meaningful and genuinely informed consent to the 
procedure. 
 
IV. LONG-TERM PREDICTIVE HEALTH ANALYTICS 
CONCERNS 
Like genetic testing, long-term predictive health analytics are 
fraught with risks, but these are garnering too little attention.157  This 
section highlights three areas of concern, though this list is far from 
comprehensive.  It focuses on psychological harms, privacy and 
discrimination, and erroneous predictions. 
A. Psychological Harms 
                                                            
151 Id. at 1233.  See also, Quaid, supra note 110, at 115-17 (discussing testing 
guidelines for Huntington’s disease, including those addressing predictive testing 
of minors). 
152 Practice Guidelines, AM. COLL. OF MED. GENETICS & GENOMICS, 
https://www.acmg.net/ACMG/Medical-Genetics-Practice-Resources/Practice-
Guidelines.aspx (last visited Mar. 7, 2019). 
153 Burke, supra note 74, at 1873.   
154 Id. 
155 ANDREWS ET AL., supra note 77, at 329; About NSGC:  The Leading Voice for 
Genetic Counselors, NAT’L SOC’Y OF GENETIC COUNSELORS, 
https://www.nsgc.org/page/about-nsgc (last visited Mar. 7, 2019). 
156 Mission Statement, Purpose and Values, AM. BD. OF GENETIC COUNSELORS, 
https://www.abgc.net/about-abgc/mission-history/ (last visited Mar. 7, 2019). 
157 I. Glenn Cohen & Harry S. Graver, Cops, Docs, and Code: A Dialogue between 
Big Data in Health Care and Predictive Policing, 51 U.C. DAVIS L. REV. 437, 
446 (2017) (“The legal literature on predictive analytics in health care is at this 
moment less robust than that on predictive policing, although that is changing.”).  
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Predictions of future ailments based on predictive health 
analytics can be just as traumatizing as predictions based on genetic 
testing.158  Individuals who learn from their doctors that they are 
likely to develop heart disease, dementia, or psychosis in the future 
might feel that the news is devastating.159    As a result, they could 
have difficulty concentrating on work, experience strain in their 
relationships, or even become clinically depressed or suicidal.160  
Like genetic testing of children, predictive health analytics 
involving minors raise particularly troubling questions.161  
Worrisome predictions can adversely impact children’s futures and 
disrupt family dynamics.162 
Physicians who identify certain individuals as vulnerable to 
opioid addiction, cognitive decline, or suicide163 may treat those 
patients differently, to the patients’ detriment.  For example, they 
may refuse to provide potential opioid addicts with needed pain 
medication.164  They may also relate to patients at risk of dementia 
or suicide poorly, treating them as cognitively compromised or 
lacking autonomy even when they are fully competent.165  So too 
they may try to drive patients who are labelled as potentially high-
risk and high-cost away from their practices.166 
It is also likely that many individuals will obtain distressing 
health predictions not from their doctors, but from commercial 
enterprises, without being aware in advance that anyone has 
assessed their health risks.  Data brokers sell health information to 
interested buyers, and companies such as LexisNexis and Acxiom 
have already begun to engage in predictive health analytics.167 
Marketers will likely be eager to obtain health predictions about 
patients in order to tailor their marketing materials effectively.168 
Imagine individuals receiving the news that they are at risk of 
cognitive decline through an electronic advertisement urging them 
to purchase memory-enhancing products!  People who do not have 
                                                            
158 See supra Part III.B.3. 
159 See supra Part II.B. 
160 See supra notes 104-106 and accompanying text. 
161 See supra notes 111-115 and accompanying text. 
162 Id. 
163 See supra Part II.B. 
164 Ravindranath, supra note 66. 
165 Marks, supra note 12, at __ (“Patients with mental illnesses often report feeling 
dehumanized and dismissed by healthcare providers.”). 
166 Cohen et al., supra note 5, at 1141. 
167 See supra notes 66-73 and accompanying text. 
168 Cobb, supra note 73; HOFFMAN, supra note 26, at 60. 
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the support of a physician and do not receive a clear, medical 
explanation of the prediction and its degree of certainty will be all 
the more vulnerable to distress and misunderstandings.  
 
B. Privacy and Discrimination 
 
Because the HIPAA Privacy Rule governs only a subset of 
parties that possess health information,169 not all predictive health 
analytics outcomes will be subject to privacy protections.170  Entities 
that are not health plans, health care clearinghouses and health care 
providers or their business associates are not legally bound to refrain 
from disclosing health information about patients.171  Thus, data 
brokers are permitted to sell health-related information to 
marketers.172  Moreover, entities that are not covered by HIPAA 
could disclose and publicize individually identifiable predictive 
health analytics results. One can imagine the media obtaining 
predictions about entertainers and politicians that can cause 
significant embarrassment and even ruin careers. Predictions about 
ordinary people could likewise be widely publicized through social 
media and be available to anyone with an electronic device. 
It is also noteworthy that non-covered entities are not subject to 
the requirements of the HIPAA Security Rule.173  Thus, such entities 
may be tempted to use security shortcuts and may be vulnerable to 
hacking and other data breaches.174  Data stored by commercial 
enterprises for predictive health analytics purposes, consequently, 
may be more vulnerable to privacy violations than HIPAA-protected 
health information. 
Given the HIPAA Privacy Rule’s limitations, individuals’ health 
predictions can easily land in the hands of third parties who may use 
them to further their own economic agendas.175  Employers, lenders, 
                                                            
169 See supra note 142 and accompanying text. 
170 Marks supra note 12, at __ (discussing privacy risks related to suicide 
predictions). 
171 Id.; 45 C.F.R. §§ 160.102–.103 (2018); 42 U.S.C. § 17934 (2010). 
172 Erin McCann, What HIPAA Doesn’t Cover, HEALTHCARE IT NEWS (July 16, 
2014), https://www.healthcareitnews.com/news/what-hipaa-doesnt-cover.  
173 Sharona Hoffman & Andy Podgurski, supra note 140, at 344-47. 
174 Id. at 332-34 (discussing various data breaches); Topol, supra note 4, at 52 
(noting “the risk of deliberate hacking 
of an algorithm to harm people at a large scale”). 
175 HOFFMAN, supra note 26, at 59-60 (listing a variety of parties that could be 
interested in people’s health data). 
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life insurers, and others with a stake in individuals’ future wellbeing 
may be interested in predictions about individuals’ future health 
status.176  Employers for example, are interested in employees who 
will not have productivity or absenteeism problems and will not 
generate high health insurance costs.177  They may be very tempted 
to reject or terminate workers who they believe to be at high risk of 
becoming seriously ill in the coming years.  Similarly, lenders seek 
borrowers who will remain able to work and pay off their loans, and 
life insurers may use predictive information about applicants to 
make eligibility or pricing decisions.178 
Currently, the anti-discrimination laws do not prohibit 
employers and others from discriminating based on predictions of 
future health problems (other than predictions based on genetic 
information, which are covered by GINA).179  The Americans with 
Disabilities Act (ADA), the primary federal disability 
discrimination law, prohibits discrimination related only to: 
(A) a physical or mental impairment that substantially 
limits one or more major life activities of such 
individual; 
(B) a record of such an impairment; or 
(C) being regarded as having such an impairment.180 
Consequently, it does not reach discrimination based on future 
physical or mental impairments or disabilities.  This legislative gap 
creates worrisome opportunities for discrimination based on disease 
predictions. 
 Predictive health analytics may also perpetuate other types 
of discrimination, such as sex or race-based discrimination.  
Amazon’s effort to develop artificial intelligence-driven software to 
identify the best job candidates illustrates the point.181  Because the 
predictive model’s training data were past resumes submitted to 
Amazon mostly by men, the program was biased against women and 
                                                            
176 Sharona Hoffman, Big Data’s New Discrimination Threats:  Amending the 
Americans with Disabilities Act to Cover Discrimination Based on Data-Driven 
Predictions of Future Disease, in BIG DATA, HEALTH LAW, AND BIOETHICS 85, 
85 (I. Glenn Cohen et al. eds., 2018). 
177 Id. at 86. 
178 HOFFMAN, supra note 26, at 60; Marks, supra note 12, at __. 
179 Hoffman supra note 176, at 92–94. 
180 42 U.S.C. § 12102(1) (2010).  
181 Katherine Maher, Without Humans, A.I. Can Wreak Havoc, N.Y. TIMES, Mar. 
12, 2019, https://www.nytimes.com/2019/03/12/opinion/artificial-intelligence-
wikipedia.html?smid=nytcore-ios-share. 
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concluded men were preferable job candidates.182  It is just as likely 
that predictive models in the healthcare arena will be biased and 
wrongly conclude that women are at higher risk of various health 
problems.  Likewise, if companies such as LexisNexis and Acxiom 
base predictive models on variables that include criminal records 
and voter registration data,183 they could disproportionately identify 
certain minorities as high-risk patients. 
 
C. Erroneous Predictions 
To make matters worse, the results of predictive health analytics 
can often be wrong.184 In one illustrative example outside the health 
field, scientists produced “fooling images” that were completely 
unrecognizable to humans, but deep neural networks (a form of 
machine learning) believed “with near certainty” that they were 
familiar objects.185  Flawed outcomes can stem from a variety of 
problems.   
One reason can be human error in the algorithm or its 
implementation.  Big data used to train computers and develop 
learning algorithms can be rife with inaccuracies and data gaps or 
otherwise be a poor fit for the task at hand.186  Poor data quality will 
inevitably lead to poor data-driven artificial intelligence algorithms, 
consistent with the “garbage in-garbage out” principle.187 
Even with a correct learning algorithm, the performance the 
predictive model exhibits using the training data188 may not 
                                                            
182 Id.  See infra Part IV.C for a discussion of bias. 
183 Ravindranath, supra note 66. 
184 Ian A. Scott, Hope, Hype and Harms of Big Data, 49 INTERNAL MED. J. 126, 
127 (2019). 
185 Anh Nguyen et al., Deep Neural Networks are Easily Fooled: High Confidence 
Predictions for Unrecognizable Images, COMPUTER VISION & PATTERN 
RECOGNITION, IEEE, 1, 1 (2015), available at 
https://arxiv.org/pdf/1412.1897.pdf.  
186 Scott, supra note 184, at 127 (discussing numerous potential shortcomings of 
big data); Nilay D. Shah et al., Big Data and Predictive Analytics:  Recalibrating 
Expectations, 320 JAMA 27, 28 (2018); Topol, supra note 4, at 51. 
187 P. Elliott Miller et al., Predictive Abilities of Machine Learning Techniques 
May Be Limited by Dataset Characteristics: Insights from the UNOS Database, 
J. CARDIAC FAILURE (forthcoming 2019) (manuscript at 4) (“Our results raise the 
notion that large clinical datasets might lack the accuracy and granularity needed 
for machine learning methodologies to uncover unique associations.”); Kun-
Hsing Yu & Isaac S. Kohane, Framing the Challenges of Artificial Intelligence 
in Medicine, 28 BMJ QUAL. & SAF. 238, 239 (2019). 
188 See supra notes 28-31 and accompanying text for explanation of machine 
learning. 
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generalize to real world data because of a phenomenon called 
“overfitting.”189  A particular model can produce accurate 
predictions on a set of training data but fail to provide sound 
predictions when deployed on new data, especially if the model is 
complex and the training data set was small.190  Because of the 
dearth of training data and the large number of parameters used to 
construct the model, “the learned parameters are spuriously 
inferred” and are unlikely to generalize well to unseen data.191 In 
other words, overfitting occurs when a predictive model fits the 
training data “too well.”192 
Big data can also be subject to selection bias.  If the data used to 
train learning algorithms or statistical models comes from a health 
system that serves particular populations (e.g. disproportionately 
wealthy or disadvantaged individuals) but not others, the algorithm 
or model may not be generalizable to all patients.193  Several 
scholars have noted the following: 
Big data has not captured certain marginalized demographics. 
Particularly concerning are racial minorities, people with low 
socioeconomic status, and immigrants. Many of the people 
missing from the data that come from sources such as Internet 
history, social media presence, and credit-card use are also 
missing from other sources of Big Data, such as electronic health 
records (EHRs) and genomic databases. The factors responsible 
for these gaps are diverse and include lack of insurance and the 
inability to access healthcare, to name just two….194 
Unfortunately, it is often impossible to discern whether a 
predictive model is sound.  Learning algorithms are often opaque 
because they rely on extremely complex rules and even their 
programmers are uncertain about how they ultimately work.195  
                                                            
189 CHARU C. AGRAWAL, NEURAL NETWORKS AND DEEP LEARNING 25 (2018). 
190 Id. 
191 Id. 
192 SHALEV-SHWARTZ & BEN DAVID, supra note 21 at 16. 
193 Craig Konnoth, Health Information Equity, 165 U. PA. L. REV. 1317, 1361 
(2017) (asserting that “relying on 
data that is biased towards certain social groups can have problematic effects”). 
194 Sarah E. Malanga et al., Who's Left Out of Big Data? How Big Data Collection, 
Analysis, and Use Neglects Populations Most in Need of Medical and Public 
Health Research and Interventions, in BIG DATA, HEALTH LAW, AND BIOETHICS 
98, 98–99 (I. Glenn Cohen et al. eds., 2018). 
195 Price, supra note 19, at 430; Tokio Matsuzaki, Ethical Issues of Artificial 
Intelligence in Medicine, 55 CAL. W. L. REV. 255, 269 (2018) (“One concern is 
that Al [artificial intelligence] decision-making … often has no transparency. This 
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Some commentators use the term “black box medicine” to describe 
reliance on nontransparent learning algorithms.196  
Use of the terms “artificial intelligence” and “machine learning” 
can over-awe people.  But as one commentator notes, “the only sure 
prediction about the future of big data and predictive analytics is that 
it is unlikely to live up to some of the hype.”197  Therefore, 
algorithms, in many cases, will falsely predict that individuals will 
suffer particular conditions in the future, and the affected data 
subjects will be left to suffer the consequences. 
 
V. RECOMMENDATIONS 
 
At its core, this Article is a call to action.  The policy and 
scientific communities must not ignore the potential risks of 
predictive health analytics. Just as the growth of genetic testing 
elicited robust academic and policy debates, so too should the 
burgeoning phenomenon of predictive health analytics.  Effective 
legal and policy interventions are needed to safeguard the rights of 
data subjects.  This section recommends changes to the HIPAA 
Privacy and Security Rules and to the Americans with Disabilities 
Act.  It also advocates for the implementation of other oversight and 
self-regulation mechanisms. 
A. Legal Interventions 
 
Legislators should modify the laws that establish privacy and 
anti-discrimination mandates.  This section focuses on the federal 
HIPAA Privacy and Security Rules and Americans with Disabilities 
Act, though states could make similar changes to parallel state 
laws.198 It also briefly examines whether the Food and Drug 
Administration (FDA) could regulate learning algorithms used for 
long-term predictive health analytics. 
                                                            
means that doctors and patients are not able to know how the Al system reached 
the decision.”). 
196 Price, supra note 19, at 429; Topol, supra note 4, at 51. 
197 Shah et al., supra note 186, at 28. 
198 See Sharona Hoffman, Medical Privacy and Security, in THE OXFORD 
HANDBOOK OF U.S. HEALTHCARE LAW 267, 273–79 (I. Glenn Cohen et al. eds., 
2015) (discussing state privacy laws); Disability Discrimination: State Law, 
WORKPLACE FAIRNESS, https://www.workplacefairness.org/disability-
discrimination-state-law (last visited Mar. 15, 2019). 
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1. The HIPAA Privacy and Security Rules 
 
As I have argued in other work,199 Congress and the Department 
of Health and Human Services should expand HIPAA’s definition 
of “covered entity.”200  The need for change has become all the more 
urgent in light of the growing use of predictive health analytics.  The 
federal law and regulations should adopt the language of a much 
broader Texas privacy statute: 
"Covered entity" means any person who: 
(A)  for commercial, financial, or professional gain, 
monetary fees, or dues, or on a cooperative, nonprofit, or pro 
bono basis, engages, in whole or in part, and with real or 
constructive knowledge, in the practice of assembling, 
collecting, analyzing, using, evaluating, storing, or transmitting 
protected health information.  The term includes a business 
associate, health care payer, governmental unit, information or 
computer management entity, school, health researcher, health 
care facility, clinic, health care provider, or person who 
maintains an Internet site; 
(B)  comes into possession of protected health information; 
(C)  obtains or stores protected health information under this 
chapter;  or 
(D)  is an employee, agent, or contractor of a person described 
by Paragraph (A), (B), or (C) insofar as the employee, agent, or 
contractor creates, receives, obtains, maintains, uses, or transmits 
protected health information.201  
This change would require a parallel modification to the 
definition of “health information.”202  “Health Information” should 
                                                            
199 HOFFMAN, supra note 26, at 74. 
200 Hoffman & Podgurski, supra note 140, at 360-363. 
201 TEX. HEALTH & SAFETY CODE ANN. § 181.001(b)(2) (West 2017).   
202 “Health information” currently means:  
 
any information, whether oral or recorded in any form or medium, that –  
(A) is created or received by a health care provider, health plan, public 
health authority, employer, life insurer, school or university, or health 
care clearinghouse; and  
 
(B) relates to the past, present, or future physical or mental health or 
condition of an individual, the provision of health care to an individual, 
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be expanded to mean “any information, recorded in any form or 
medium, that relates to the past, present, or future physical or mental 
health or condition of an individual, including health predictions, the 
provision of healthcare to an individual, or the past, present, or 
future payment for the provision of healthcare to an individual.”203   
 Expanding the definitions of “covered entities” and “health 
information” would not prevent healthcare providers from 
contracting with business associates such as LexisNexis or Axciom 
to conduct predictive health analytics so long as they did so for 
purposes of treatment, payment, or health care operations.204  It also 
would not prevent data brokers from accessing much of the data they 
use, such as Facebook posts, shopper loyalty program records, or 
voter registration data.205   
 Nevertheless, the change would provide patients with 
several important benefits.  First, it would prevent the newly covered 
entities from disclosing health predictions to third parties without 
the data subject’s consent. These predictions would constitute health 
information about individuals’ future physical or mental health 
conditions, and thus data brokers and other commercial enterprises 
could not sell them without permission to marketers, employers, and 
other interested parties for financial gain.  Second, upon request, the 
newly covered entities would be bound to inform data subjects of all 
disclosures of their protected health information that were made.206  
Third, the newly covered entities would have to comply with the 
security mandates of the HIPAA Security Rule.207  They therefore 
would be prohibited from storing health information and health 
predictions about individuals with sloppy or minimal security 
measures that do not adequately deter hacking.   
 In addition, the HIPAA Privacy and Security Rules should 
include a private cause of action.208  Because of budgetary 
                                                            
or the past, present, or future payment for the provision of health care to 
an individual. 
 
45 C.F.R. § 160.103 (2018); 42 U.S.C. § 1320d(4) (2000).   
203 See HOFFMAN, supra note 26, at 75. 
204 See supra note 146 and accompanying text. 
205 See supra Parts II.C. & D; proposed definition of “health information,” supra 
note 203 and accompanying text. 
206 45 C.F.R. §§ 164.520(b)(1)(iv), .528 (2018). 
207 45 C.F.R. §§ 164.302–.318 (2018); see supra notes 140-141 and accompanying 
text. 
208 See HOFFMAN, supra note 26, at 78-9; supra notes 143-144 and accompanying 
text (discussing the absence of a private cause of action). 
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constraints, government enforcement is often anemic.209 
Furthermore, it does not provide aggrieved parties with monetary 
relief if they have suffered injury resulting from a privacy breach.210  
The proposed HIPAA changes could meaningfully enhance data 
subjects’ privacy protections and rights.   
2. The Americans with Disabilities Act 
I have also previously argued for a broadening of the Americans 
with Disabilities Act’s (ADA) definition of “disability,” and I renew 
my call for this change here.211  The ADA’s “regarded as” provision 
protects only individuals who are “being regarded as [currently] 
having … an impairment.”212  Congress should revise the “regarded 
as” provision of the ADA to include individuals who “are perceived 
as likely to develop physical or mental impairments in the future.”213   
This change would prohibit employers and other parties from 
discriminating against individuals because of disease predictions.214   
It follows logically from GINA, which forbids discrimination based 
on a specific type of predictive data - genetic information.215  In the 
era of predictive health analytics, there is no justification for 
retaining a discrepancy between GINA and the ADA.  This is 
particularly true because predictive models can forecast inherited 
diseases such as heart conditions and some forms of Alzheimer’s 
disease.216  Presumably, GINA would not cover such predictions 
because they are not based on genetic tests or family histories.217  
The law should not leave individuals who are identified as being at 
risk for future diseases vulnerable to discrimination and protect 
them only if the prediction is rooted directly in genetic information.  
With respect to anti-discrimination mandates, genetic 
exceptionalism218 no longer makes sense. 
                                                            
209 Morgan Leigh Tendam, The HIPAA-Pota-Mess: How HIPAA's Weak 
Enforcement Standards Have Led States To Create Confusing Medical Privacy 
Remedies, 79 OHIO ST. L.J. 411, 421-22 (2018). 
210 See HOFFMAN, supra note 26, at 75-76. 
211 Sharona Hoffman, Big Data and the Americans with Disabilities Act, 68 
HASTINGS L.J. 777, 787-88 (2017). 
212 42 U.S.C. § 12102(1)(C) (2010). 
213 Hoffman, supra note 211 at 787. 
214 Hoffman, supra note 176, at 94–96. 
215 See supra Part III.C.1. 
216 See supra Parts II.B & C and note 81 and accompanying text. 
217 See supra Part III.C.1. 
218 Genetic exceptionalism is the belief that genetic information is special and 
should be treated differently from other health data.  James P. Evans & Wylie 
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3. FDA Regulation? 
Genetic tests are subject to regulation by the FDA and the 
Centers for Medicare and Medicaid Services (CMS), which 
oversees clinical laboratories.219  CMS would not regulate learning 
algorithms because no clinical laboratories are involved, and a real 
question exists as to whether the FDA will routinely do so. 
The FDA regulates medical devices, which are defined as any 
“instrument, apparatus, implement, machine, contrivance, implant, 
in vitro reagent, or other similar or related article which is intended 
for use in the diagnosis of disease or other conditions, or in the cure, 
mitigation, treatment, or prevention of disease, in man or other 
animals.”220  Arguably, the FDA has authority to regulate learning 
algorithms as contrivances that are used for the diagnosis and 
prevention of disease.221 In early 2018 the FDA in fact approved an 
algorithm.222  It provided premarket clearance for the WAVE 
Clinical Platform, an early-warning system for hospitals that uses 
vital sign data to identify patients at risk of becoming unstable.223 
 Even under this liberal interpretation, however, the agency is 
empowered to regulate only algorithms used for medical care.224  It 
would not have jurisdiction over predictive health analytics 
conducted by marketers, employers, or other parties for nonmedical 
purposes.225  
Moreover, the FDA has traditionally refrained from regulating 
the practice of medicine.226 Thus, it may hesitate to regulate learning 
algorithms when their use seems akin to medical practice.227   While 
WAVE may be classified as a device designed to predict imminent 
medical crises,228 long-term predictive analytics are a poorer match.  
                                                            
Burke, Genetic Exceptionalism. Too Much of a Good Thing?, 10 GENETICS IN 
MED. 500, 500 (2008). 
219 Regulation of Genetic Tests, NAT’L HUMAN GENOME RESEARCH INST., 
https://www.genome.gov/10002335/regulation-of-genetic-tests/ (last updated 
Jan. 17, 2018). 
220 21 U.S.C. § 321(h) (2012). 
221 Price, supra note 19, at 439. 
222 Ravi B. Parikh et al., Regulation of Predictive Analytics in Medicine, 363 
SCIENCE 810, 811 (2019). 
223 Id.; How WAVE Works, EXCEL MED., https://www.excel-medical.com/how-
wave-works (last visited Mar. 16, 2019). 
224 See supra, Parts II.B, C, & D. 
225 See supra notes 71-73 and accompanying text. 
226 Price, supra note 19, at 441. 
227 Id. at 441-42.  See also Cortez, supra note 27, at 78. 
228 Parikh et al., supra note 222, at 811. 
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At best, they merely assist physicians in making decisions about a 
patient’s future care.   
Professor Nathan Cortez argues that predictive health analytics 
do not fit comfortably into any of the familiar categories of medical 
products, medical practice, or medical information for regulatory 
purposes.229  He and others argue for a new regulatory paradigm.230 
Resolving the controversy regarding FDA regulation of learning 
algorithms is beyond the scope of this paper.  Suffice it to say that 
no governing authority regularly scrutinizes learning algorithms 
before they are deployed in order to ensure their quality.  Long-term 
health predictions can significantly impact people’s lives.  Much 
more must be done to construct thoughtful, responsible legal 
oversight mechanisms for predictive health analytics. 
 
B. Other Oversight Mechanisms 
Academics and other experts have begun building a literature 
about the legal and ethical implications of predictive health analytics 
only in recent years.231  It is a long way from reaching the 
proportions of the genetic testing literature.  Moreover, existing 
literature has paid little attention to long-term predictive health 
analytics, which raise unique concerns about psychological harms 
and discrimination.232  Legal and bioethics scholars should no more 
ignore these risks than they did the risks of genetic testing.  What 
follows is a brief discussion of potential oversight improvements for 
the predictive health analytics industry and medical professionals. 
1. Predictive Health Analytics Oversight  
A few papers have undertaken the development of initial 
guidelines for predictive health analytics.233 For example, a panel of 
                                                            
229 Cortez, supra note 27, at 81.  See also, Parikh et al., supra note 222, at 811 
(stating that “existing FDA standards do not neatly translate to advanced 
predictive algorithms”). 
230 Cortez, supra note 27, at 81-85; Price, supra note 19, at 457-59 (calling for 
reform and suggesting that the FDA should regulate predictive health analytics in 
collaboration with other health care stakeholders). 
231 Cohen & Graver, supra note 157, at 446.  
232 See supra Parts IV A & B. 
233 See Ruben Amarasingham et al., Consensus Statement on Electronic Health 
Predictive Analytics:  A Guiding Framework to Address Challenges, 4 EGEMS 
Iss. 1, Art. 3 (2016), available at 
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seventeen experts proposed the following guiding principles in 
2016: 
1. Data Barriers:  Establish mechanisms within the scientific 
community to support data sharing for predictive model 
development and testing. 
2. Transparency:  Set standards around e-HPA validation based 
on principles of scientific transparency and reproducibility. 
3. Ethics:  Develop both individual-centered and society-
centered risk-benefit approaches to evaluate e-HPA. 
4. Regulation and Certification:  Construct a self-regulation 
and certification framework within e-HPA. 
5. Education and Training:  Make significant changes to 
medical, nursing, and paraprofessional curricula by 
including training for understanding, evaluating, and 
utilizing predictive models.234 
The scholars that have pondered predictive health analytics all 
agree that transparency and oversight are of critical importance.235  
They recommend the establishment of industry-wide validation and 
certification mechanisms implemented by the Joint Commission, 
certifiers overseen by the FDA, independent institutional review 
boards, or other third parties.236  
Experts have developed a variety of techniques to assess 
learning algorithms and predictive models.237 A popular method for 
estimating prediction error is cross-validation.238 Another method to 
assess statistical accuracy is the bootstrap method.239 Most 
importantly, researchers should validate learning algorithms in the 
field, using real patients under the same conditions as those intended 
for the algorithm’s post-approval use.240  Such validation should 
ensure that the algorithm’s predictive capability generalizes to the 
true target population.241  Oversight bodies should consist of 
                                                            
Cohen et al., supra note 5; Parikh et al., supra note 222 (proposing five criteria 
“for evaluation and regulation of predictive algorithms”). 
234 Amarasingham et al., supra note 233, at 2, 9.  E-HPA is electronic health 
predictive analytics. 
235 Id. at 5-9; Cohen et al., supra note 5, at 1142-43; Marks, supra note 12, at __. 
236 See supra note 235; Cortez, supra note 27, at 84-85. 
237 TREVOR HASTIE ET AL., THE ELEMENTS OF STATISTICAL LEARNING:  DATA 
MINING, INFERENCE, AND PREDICTION 219-57 (2d ed. 2009) (discussing model 
assessment and selection). 
238 Id. at 241-49. 
239 Id. at 249-54. 
240 Marks, supra note 12, at __ (discussing suicide prediction research). 
241 See supra Part IV.C (discussing erroneous outcomes). 
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predictive health analytics and validation experts who can be trusted 
to scrutinize proposed assessment methods and ensure that they are 
appropriate.242 
The recommendations offered thus far are sound, and experts 
should continue to develop and augment them in order to furnish 
policy-makers with proposals that are as detailed and evidence-
based as possible.  Oversight and quality control could prevent many 
erroneous predictions and save clinicians and patients considerable 
angst.   
2. Self-Regulation by the Medical Profession  
Health care professionals would be wise to adopt their own 
safeguards in order to minimize the hazards of long-term disease 
predictions for patients.  To that end, physicians should receive 
training concerning long-term predictive health analytics so that 
they understand the extent to which it can be limited and uncertain.  
They should also counsel and educate patients before disclosing 
troubling health predictions to them.  A process akin to genetic 
counseling would be very useful.243  Patients should understand the 
advantages and disadvantages of learning about their disease risks 
and be able to make informed decisions about their choice. 
 In addition, professional organizations should develop 
practice guidelines regarding when it is appropriate to employ 
predictive health analytics and the extent to which clinicians should 
rely upon them.244  For example, practice guidelines might 
recommend that clinicians refrain from obtaining certain types of 
predictions about children.245  They might also suggest which 
interventions should and should not be implemented in response to 
predictions of suicidal ideation, clinical depression, opioid addiction 
or other ailments.   Education, counseling, and practice guidelines 
could go far in maximizing the benefits and minimizing the risks of 
predictive health analytics. 
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IV.   CONCLUSION 
We should not be blinded by enthusiasm for long-term 
predictive health analytics or be naively seduced by technologies 
with impressive names like artificial intelligence and machine 
learning.  Certainly, there is much to be gained from prudent use of 
new predictive capabilities.  However, the technologies come with 
significant risks of psychological harm, privacy violations, and 
discrimination, among others.  Moreover, predictive models and 
learning algorithms are often flawed and produce erroneous 
outcomes.  Many of these potential harms were previously 
considered and addressed in the context of genetic testing.  
Scientists and policy-makers would be wise to adopt similar 
approaches for long-term predictive health analytics.  This paper has 
proposed just a few legal and non-legal interventions. These are 
designed to enhance data subjects’ privacy rights, anti-
discrimination protections, and ability to make informed decisions 
about obtaining disease predictions.  However, many more minds 
must tackle the challenges of predictive health analytics and develop 
mechanisms to enhance the integrity and benefits of these 
technologies.  Ignoring the potential perils and unintended 
consequences of long-term predictive analytics is imprudent and 
could cost society dearly. 
 
 
 
